TickerFacts.

PRF Technologies Ltd. (PRFX): Shareholders' Equity

Annual figures by period end, from SEC filings.

$8.54M
As of 2025-12-31
-8.1%
3-year compound annual growth
-12.5%
5-year compound annual growth
$18.08M2018-12-31: -$11.08M2019-12-31: -$12.24M2020-12-31: $16.62M2021-12-31: $18.08M2022-12-31: $11.02M2023-12-31: $7.24M2024-12-31: $1.82M2025-12-31: $8.54M$8.54M
2018-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31$8.54M+368.4%2026-03-26, Balance as of period end
2024-12-31$1.82M-74.8%2026-03-26, Balance as of period end
2023-12-31$7.24M-34.3%2025-04-07, Balance as of period end
2022-12-31$11.02M-39.0%2025-04-07, Balance as of period end
2021-12-31$18.08M+8.8%2024-02-29, Balance as of period end
2020-12-31$16.62Mn/m2023-03-15, Balance as of period end
2019-12-31-$12.24Mn/m2022-03-16, Balance as of period end
2018-12-31-$11.08Mn/a2021-03-18, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
PRF Technologies Ltd. (PRFX)2025-12-31$8.54M+368.4%
Bioadaptives, Inc. (BDPT)2025-12-31-$2.13Mn/m
Skinvisible, Inc. (SKVI)2025-12-31-$10.26Mn/m
Jupiter Neurosciences, Inc. (JUNS)2025-12-31-$1.83Mn/m
Talphera, Inc. (TLPH)2025-12-31$17.04M+112.9%
Impact Biomedical Inc. (IBO)2025-12-31$12.61M+196.1%
Lyell Immunopharma, Inc. (LYEL)2025-12-31$248.20M-35.2%
Genelux Corp (GNLX)2025-12-31$11.54M-56.1%
Neonc Technologies Holdings, Inc. (NTHI)2025-12-31-$17.51Mn/m

Compare PRFX, BDPT, SKVI, JUNS side by side · Screen every company in Pharmaceutical Preparations ↗